PTPRG expression (both at mRNA and protein levels) appears to be inversely correlated with the proliferative and clonogenic capacities of CML cells, and represents a disease-associated biomarker [116,117]. Here, PTPRG is linked to chronic myelogenous leukemia, BCR-ABL1 positive.